|
|
Other links at Articles > Cardiology |
| 4. |
Further Evidence of CV Harm With Rosiglitazone
|
|
|
More evidence supporting the idea that rosiglitazone does increase the risk for cardiovascular events has come from a new population-based study of older patients with diabetes. Medscape Medical News
|
| 5. |
Echo Contrast Agents "Safe"; FDA Should Reconsider Warnings
|
|
|
A new analysis has shown that the benefits of using ultrasound contrast agents outweigh the risks. Most important, withholding the use of such agents in patients who need them can be detrimental, says the lead investigator. Reporting her findings last week, she called on the FDA to reconsider the warnings it has placed on these products. Heartwire
|
|
|
